Focal begins surgical sealant trial
This article was originally published in Clinica
Focal has begun a clinical trial of its FocalSeal surgical sealant for minimally-invasive surgery for lung volume reduction at a leading European thoracic surgery centre. FocalSeal is a synthetic, absorbable liquid for sealing air and fluid leaks. The product will be distributed by Johnson & Johnson subsidiary Ethicon (see Clinica No 740, p 13).